28-29 October: we’re attending World Orphan Drug Congress 2025 in Amsterdam!

Paspigioni is excited to participate in the World Orphan Drug Congress 2025 in Amsterdam, the foremost global meeting for orphan drug and rare disease innovation. Our team provides comprehensive end-to-end clinical trial management, regulatory submission, and market access solutions - driving breakthroughs from gene therapy to real-world evidence. Meet us among 130+ solution providers as we foster novel partnerships shaping the future of rare disease research.

We look forward to engaging with partners and bringing fresh insights back to our organization. If you’re attending, let’s connect in Amsterdam!